Portal de Periódicos da CAPES

Chronic adiponectin deficiency leads to Alzheimer’s disease-like cognitive impairments and pathologies through AMPK inactivation and cerebral insulin resistance in aged mice

2016; BioMed Central; Volume: 11; Issue: 1 Linguagem: Inglês

10.1186/s13024-016-0136-x

1750-1326

Roy Chun-Laam Ng, On-Yin Cheng, Min Jian, Jason Shing-Cheong Kwan, Philip Wing‐Lok Ho, Kenneth K.Y. Cheng, Patrick Ka Kit Yeung, Lena Zhou, Ruby L.C. Hoo, Sookja Kim Chung, Aimin Xu, Karen S.L. Lam, Koon Ho Chan,

Retinoids in leukemia and cellular processes

Insulin resistance is the major pathogenesis underlying type 2 diabetes mellitus (T2DM) and these patients have doubled risk of Alzheimer's disease (AD). Increasing evidence suggests that insulin resistance plays an important role in AD pathogenesis, possibly due to abnormal GSK3β activation, causing intra- and extracellular amyloid-beta (Aβ) accumulation. Adiponectin (APN) is an adipokine with insulin-sensitizing and anti-inflammatory effects. Reduced circulatory APN level is associated with insulin resistance and T2DM. The role of APN in AD has not been elucidated. In this study, we aim to examine if adiponectin deficiency would lead to cerebral insulin resistance, cognitive decline and Alzheimer's-like pathology in mice.